News
Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click for my updated look at VIR ...
Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...
Richard Lepke; Senior Director, Investor Relations; Vir Biotechnology Inc. Marianne De Backer; Chief Executive Officer, Director; Vir Biotechnology Inc. Mark Eisner; ...
Title: ALG-055009, a potent and selective thyroid hormone receptor beta agonist for the treatment of metabolic ...
Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...
Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.
White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.
A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, ...
3d
The Business & Financial Times on MSNLiver cancer prevalence one of the world’s highestBBy Sandra Agyeiwaa OTOOGhana has been identified as having one of the highest rates of liver cancer globally, with health professionals attributing this alarming statistic primarily to the widespread ...
Introduction: Infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is a public health problem ...
24, 2025 — A comprehensive study shows that people with fatty liver disease ... fatty liver diseases ... Interventions Identified to Eliminate Transmission of Hepatitis B in Africa Feb. 27 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results